The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here ...

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

Experts have expressed frustration over the lack of clear government messaging on what the public can expect from COVID ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

CBS News Bay Area anchor Elizabeth Cook asks Dr. Laleh Gharahbaghian, medical director of adult emergency medicine at Stanford Hospital, about the FDA's proposal to move to annual Covid boosters, ...

The advisory panel mostly agreed with the FDA ... kids of immigrants COVID-19 vaccines have saved millions of lives and ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

Booster shots over the winter were "bivalent ... use of current COVID-19 vaccines, and if it is the moment to implement a more routine approach to periodically updating the strain composition," Dr.